Search
Jan 9, 2024
Galápagos CEO Paul Stoffels on the company's $3.8B cash balance and decentralized CAR-T program
Paul Stoffels describes how his company's decentralized CAR-T process is designed to have a shorter 'brain-to-vein' time.
Also look for unique social pages for BiotechTV U.
At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.